Aug 10 (Reuters) - Biohit Oyj BIOBV.HE :
* BIOHIT GROUP HALF YEAR FINANCIAL REPORT 2022
* H1 REVENUE EUR 6.1 MILLION (EUR 4.0 MILLION)
* H1 OPERATIVE EBITDA EUR 1.7 MILLION VERSUS LOSS EUR 0.2
MILLION
YEAR AGO
* EXPECTS ITS EBIT TO BE POSITIVE IN 2022 (2021: -1.5
MILLION
EUROS)
* MAIN RISKS ARE LINKED TO WEAKENING GLOBAL ECONOMIC OUTLOOK
AND
RISING INFLATION THAT IS A THREAT TO COST COMPETITIVENESS.
Source text for Eikon: ID:nWkr584YbV
Further company coverage: BIOBV.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))